← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Proteovista, Llc
Madison, WI
$3,679,160
Total funding
9
Grants
Funding over time
peak $600K · FY2011–23$1M$750K$500K$250K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$3,679,160 · 9
By mechanism
R43$1,980,231 · 6
R21$1,098,929 · 2
N43$600,000 · 1
Investigators at Proteovista, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
DEVELOPMENT OF APTAMERS TO RECOGNIZE NOD-LIKE RECEPTORS IN ZEBRAFISH$600,000
N43 · FY2021 · AI
Development of GenomeBuild as a Universal Method to Synthesize Genomes$376,800
R43 · FY2023 · HG
Aptamer-Based Detection of Cardiac Biomarker Glycosylation States Using APT-SNAP$326,050
R43 · FY2016 · HL
Aptamer-Based Detection of Cardiac Biomarker Glycosylation States Using APT-SNAP$317,350
R43 · FY2014 · HL
Development of the High Throughput APT-SNAP Platform for Rapid Identification ofNuclease-Resistant RNA Aptamers against p53 Missense Mutations$224,527
R43 · FY2019 · CA
Site-Specific Incorporation of Phosphorylation Modifications on the SNAP-Tide High Density Peptide Array$222,678
R43 · FY2018 · CA
Screening of FoxA1-ER-DNA disruptors for development of breast cancer therapeutic$218,168
R43 · FY2011 · CA
High Density Peptide Arrays for Cancer-Related Post-Translational Modifications$208,123
R21 · FY2013 · CA
High Density Peptide Arrays for Cancer-Related Post-Translational Modifications$207,796
R21 · FY2014 · CA
SNAP-X: Development of a Mutagenesis Strategy and High Density Protein Array to Comprehensively Display Protein Variants$168,410
R21 · FY2019 · CA
SNAP-X: Development of a Mutagenesis Strategy and High Density Protein Array to Comprehensively Display Protein Variants$168,410
R21 · FY2020 · CA
High Throughput Method to Assess SNP Functionality in Prostate Cancer$150,000
R43 · FY2011 · CA
High Throughput Method to Assess SNP Functionality in Prostate Cancer$144,658
R43 · FY2012 · CA
SNAP-X: Development of a Mutagenesis Strategy and High Density Protein Array to Comprehensively Display Protein Variants$129,050
R21 · FY2020 · CA
SNAP-X: Development of a Mutagenesis Strategy and High Density Protein Array to Comprehensively Display Protein Variants$110,028
R21 · FY2022 · CA
High Density Peptide Arrays for Cancer-Related Post-Translational Modifications$107,112
R21 · FY2015 · CA